|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
MXPA05002887A
(es)
*
|
2002-09-16 |
2005-05-27 |
Glaxo Group Ltd |
Compuestos de pirazolo[3,4-b]piridina, y su uso como inhibidores de fosfodiesterasa.
|
|
GB0230045D0
(en)
|
2002-12-23 |
2003-01-29 |
Glaxo Group Ltd |
Compounds
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2005058892A1
(en)
*
|
2003-12-19 |
2005-06-30 |
Glaxo Group Limited |
Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
|
|
GB0405933D0
(en)
*
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
|
AU2005223351A1
(en)
*
|
2004-03-16 |
2005-09-29 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
|
|
WO2005118543A1
(ja)
*
|
2004-06-03 |
2005-12-15 |
Ono Pharmaceutical Co., Ltd. |
キナーゼ阻害薬およびその用途
|
|
EP1841780B1
(en)
|
2005-01-10 |
2011-07-27 |
Glaxo Group Limited |
Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
|
|
JP5084725B2
(ja)
|
2005-06-06 |
2012-11-28 |
武田薬品工業株式会社 |
有機化合物
|
|
AU2006264170A1
(en)
*
|
2005-06-27 |
2007-01-04 |
Ambrilia Biopharma Inc. |
Pyrazolo[3,4-b]pyridin-2-yl)-benzoic acid derivatives as HIV integrase inhibitors
|
|
JP5114395B2
(ja)
*
|
2005-06-30 |
2013-01-09 |
プロシディオン・リミテッド |
Ｇｐｃｒアゴニスト
|
|
US20090221644A1
(en)
*
|
2005-06-30 |
2009-09-03 |
Stuart Edward Bradley |
Gpcr Agonists
|
|
EP1931668A2
(en)
|
2005-09-16 |
2008-06-18 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors
|
|
US7915286B2
(en)
|
2005-09-16 |
2011-03-29 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
|
JP5323484B2
(ja)
*
|
2005-09-29 |
2013-10-23 |
グラクソ グループ リミテッド |
ピラゾロ［３，４−ｂ］ピリジン化合物及びそのＰＤＥ４阻害薬としての使用
|
|
TW200730498A
(en)
|
2005-12-20 |
2007-08-16 |
Glaxo Group Ltd |
Compounds
|
|
CA2645137A1
(en)
*
|
2006-03-07 |
2007-09-13 |
James F. Blake |
Heterobicyclic pyrazole compounds and methods of use
|
|
KR20090003349A
(ko)
|
2006-04-20 |
2009-01-09 |
글락소 그룹 리미티드 |
화합물
|
|
EP2032585B1
(de)
|
2006-05-24 |
2014-07-23 |
Boehringer Ingelheim International GmbH |
Substituierte pteridine als therapeutika
|
|
WO2007143705A2
(en)
|
2006-06-06 |
2007-12-13 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
|
AR061571A1
(es)
|
2006-06-23 |
2008-09-03 |
Smithkline Beecham Corp |
Compuesto sal del acido toluenosulfonico de 4-{[6-cloro-3-({[(2- cloro-3-fluorofenil) amino]carbonil} amino)- 2- hidroxifenil]sulfonil] -1- piperazinacarbxilato de 1.1-dimetiletilo, composicion farmaceutica que lo comprende su uso para la fabricacion de un medicamento combinacion farmaceutica con un
|
|
GB0614570D0
(en)
*
|
2006-07-21 |
2006-08-30 |
Glaxo Group Ltd |
Compounds
|
|
CA2659539A1
(en)
|
2006-08-01 |
2008-02-07 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
|
|
US8492378B2
(en)
*
|
2006-08-03 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
GSK-3β inhibitor
|
|
JP5837278B2
(ja)
|
2006-12-05 |
2015-12-24 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
新規使用
|
|
US20110130403A1
(en)
*
|
2007-03-14 |
2011-06-02 |
Ranbaxy Laboratories Limited |
Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
|
|
SI2124944T1
(sl)
*
|
2007-03-14 |
2012-05-31 |
Ranbaxy Lab Ltd |
Derivati pirazolo b piridina kot inhibitorji fosfodiesteraze
|
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
|
AU2008302570B2
(en)
|
2007-09-20 |
2012-05-31 |
Irm Llc |
Compounds and compositions as modulators of GPR119 activity
|
|
US8080546B2
(en)
|
2007-10-26 |
2011-12-20 |
Amgen Inc. |
Pyrazolo-pyridinone derivatives and methods of use
|
|
JP5701608B2
(ja)
*
|
2007-12-06 |
2015-04-15 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
有機化合物
|
|
PE20091563A1
(es)
*
|
2008-02-06 |
2009-11-05 |
Glaxo Group Ltd |
Farmacoforos duales - antagonistas muscarinicos de pde4
|
|
WO2009100170A1
(en)
*
|
2008-02-06 |
2009-08-13 |
Glaxo Group Limited |
Dual pharmacophores - pde4-muscarinic antagonistics
|
|
AR070562A1
(es)
|
2008-02-06 |
2010-04-21 |
Glaxo Group Ltd |
Farmacoforos duales - antagonistas muscarinicos de pde4
|
|
PE20091553A1
(es)
|
2008-02-06 |
2009-10-30 |
Glaxo Group Ltd |
Farmacoforos duales - antagonistas muscarinicos de pde4
|
|
WO2009100169A1
(en)
*
|
2008-02-06 |
2009-08-13 |
Glaxo Group Limited |
Dual pharmacophores - pde4-muscarinic antagonistics
|
|
EP2100599A1
(en)
*
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100598A1
(en)
*
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
BRPI0912267A2
(pt)
|
2008-05-23 |
2015-10-13 |
Amira Pharmaceuticals Inc |
sal farmaceuticamente aceitável, composição farmacêutica, artigo de fabricação, métodos para tratar asma, rinite alérgica, doença, lesões gástricas e dor, métodos para prevenir broncoconstrição e rinite alérgica, uso de um sal farmaceuticamente aceitável, e, processo para a preparação de um sal farmaceuticamente aceitável.
|
|
ES2566339T3
(es)
|
2008-06-05 |
2016-04-12 |
Glaxo Group Limited |
Derivados de 4-carboxamida indazol útiles como inhibidores de PI3-quinasas
|
|
JP5438103B2
(ja)
|
2008-07-02 |
2014-03-12 |
アモーレパシフィック コーポレイション |
バニロイド受容体アンタゴニストとしての新規化合物、その異性体またはその薬学的に許容される塩、並びにそれを含む医薬組成物
|
|
AU2009306026A1
(en)
*
|
2008-09-19 |
2010-04-29 |
Ranbaxy Laboratories Limited |
Phosphodiestarase inhibitors
|
|
BRPI0922131A2
(pt)
*
|
2008-12-06 |
2015-08-18 |
Intracellular Therapies Inc |
Compostos orgânicos
|
|
BRPI0922808A2
(pt)
|
2008-12-06 |
2018-05-29 |
Intracellular Therapies Inc |
compostos orgânicos
|
|
MX2011005933A
(es)
|
2008-12-06 |
2011-12-16 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
|
BRPI0922809A2
(pt)
|
2008-12-06 |
2018-05-29 |
Intracellular Therapies Inc |
compostos orgânicos
|
|
EA201170773A1
(ru)
|
2008-12-06 |
2012-01-30 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
|
EP2367430B1
(en)
|
2008-12-06 |
2014-08-13 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
|
BRPI0924285B1
(pt)
|
2009-02-24 |
2019-04-24 |
Boydel Wastewater Technologies Inc. |
Aparelho e método para tratar água contaminada
|
|
US8524751B2
(en)
|
2009-03-09 |
2013-09-03 |
GlaxoSmithKline Intellecutual Property Development |
4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
|
|
JP2012520257A
(ja)
|
2009-03-10 |
2012-09-06 |
グラクソ グループ リミテッド |
Ｉｋｋ２阻害剤としてのインドール誘導体
|
|
EP2408769A1
(en)
|
2009-03-17 |
2012-01-25 |
Glaxo Group Limited |
Pyrimidine derivatives used as itk inhibitors
|
|
EA201171144A1
(ru)
|
2009-03-19 |
2012-04-30 |
Мерк Шарп Энд Домэ Корп. |
ОПОСРЕДОВАННОЕ РНК-ИНТЕРФЕРЕНЦИЕЙ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ ГЕНА ГОМОЛОГА 1 BTB И CNC, ОСНОВНОГО ФАКТОРА ТРАНСКРИПЦИИ С ЛЕЙЦИНОВОЙ МОЛНИЕЙ 1 (Bach1) С ИСПОЛЬЗОВАНИЕМ МАЛОЙ ИНТЕРФЕРИРУЮЩЕЙ НУКЛЕИНОВОЙ КИСЛОТЫ (миНК)
|
|
EP2408916A2
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
JP2012520685A
(ja)
|
2009-03-19 |
2012-09-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸（ｓｉＮＡ）を用いたＧＡＴＡ結合タンパク質３（ＧＡＴＡ３）遺伝子発現のＲＮＡ干渉媒介性阻害
|
|
WO2010107958A1
(en)
|
2009-03-19 |
2010-09-23 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
WO2010111468A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
|
|
US20120022143A1
(en)
|
2009-03-27 |
2012-01-26 |
Merck Sharp & Dohme Corp |
RNA Interference Mediated Inhibition of the Thymic Stromal Lymphopoietin (TSLP) Gene Expression Using Short Interfering Nucliec Acid (siNA)
|
|
US20120022142A1
(en)
|
2009-03-27 |
2012-01-26 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
|
JP2012521760A
(ja)
|
2009-03-27 |
2012-09-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸（ｓｉＮＡ）を用いたアポトーシスシグナル調節キナーゼ１（ＡＳＫ１）遺伝子発現のＲＮＡ干渉媒介性阻害
|
|
KR20110138223A
(ko)
|
2009-03-27 |
2011-12-26 |
머크 샤프 앤드 돔 코포레이션 |
짧은 간섭 핵산 (ｓｉＮＡ)을 사용한 세포간 부착 분자 1 (ＩＣＡＭ-1) 유전자 발현의 ＲＮＡ 간섭 매개 억제
|
|
EP2421834A1
(en)
|
2009-04-24 |
2012-02-29 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
US20100273744A1
(en)
|
2009-04-24 |
2010-10-28 |
Paul Martin Gore |
Compounds
|
|
CN102459253B
(zh)
|
2009-04-30 |
2015-03-25 |
葛兰素集团有限公司 |
作为pi3-激酶抑制剂的*唑取代的吲唑化合物
|
|
JP2012526810A
(ja)
|
2009-05-13 |
2012-11-01 |
イントラ−セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
US20120238559A1
(en)
|
2009-12-03 |
2012-09-20 |
Glaxo Group Limited |
Novel compounds
|
|
EP2507223A1
(en)
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of p13 kinases
|
|
WO2011067366A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
|
US8754113B2
(en)
|
2009-12-15 |
2014-06-17 |
Shionogi & Co., Ltd. |
Oxadiazole derivative having endothelial lipase inhibitory activity
|
|
WO2011107394A1
(en)
|
2010-03-01 |
2011-09-09 |
Glaxo Group Limited |
Treatment of anxiety disorders
|
|
WO2011110575A1
(en)
|
2010-03-11 |
2011-09-15 |
Glaxo Group Limited |
Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
|
TW201209054A
(en)
|
2010-05-28 |
2012-03-01 |
Prosidion Ltd |
Novel compounds
|
|
EP2590657A4
(en)
|
2010-05-31 |
2014-02-12 |
Intra Cellular Therapies Inc |
ORGANIC CONNECTIONS
|
|
US9434730B2
(en)
|
2010-05-31 |
2016-09-06 |
Intra-Cellular Therapies, Inc. |
PDE1 inhibitor compounds
|
|
WO2011153138A1
(en)
|
2010-05-31 |
2011-12-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
TW201206937A
(en)
|
2010-05-31 |
2012-02-16 |
Intra Cellular Therapies Inc |
Organic compounds
|
|
JP5965402B2
(ja)
|
2010-09-08 |
2016-08-03 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｎ−［５−［４−（５−｛［（２ｒ，６ｓ）−２，６−ジメチル−４−モルホリニル］メチル｝−１，３−オキサゾール−２−イル）−１ｈ−インダゾール−６−イル］−２−（メチルオキシ）−３−ピリジニル］メタンスルホンアミドの多形体および塩
|
|
WO2012032065A1
(en)
|
2010-09-08 |
2012-03-15 |
Glaxo Group Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
|
WO2012035055A1
(en)
|
2010-09-17 |
2012-03-22 |
Glaxo Group Limited |
Novel compounds
|
|
EP2630126B1
(en)
|
2010-10-21 |
2015-01-07 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, immune and inflammatory conditions
|
|
EP2630127A1
(en)
|
2010-10-21 |
2013-08-28 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
|
GB201018124D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Polymorphs and salts
|
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
|
US20140005188A1
(en)
|
2011-03-11 |
2014-01-02 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
WO2012171016A1
(en)
|
2011-06-10 |
2012-12-13 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2013117693A1
(en)
|
2012-02-10 |
2013-08-15 |
Glaxosmithkline Intellectual Property Development Limited |
Pde4 inhibitor for treating huntington's disease
|
|
PE20142258A1
(es)
|
2012-04-25 |
2015-01-15 |
Takeda Pharmaceutical |
Compuesto heterociclico nitrogenado
|
|
EP2873669A4
(en)
|
2012-07-13 |
2015-11-25 |
Takeda Pharmaceutical |
HETEROCYCLIC CONNECTION
|
|
EP2956141A4
(en)
|
2013-02-17 |
2016-10-26 |
Intra Cellular Therapies Inc |
NEW USES
|
|
US9834520B2
(en)
|
2013-03-14 |
2017-12-05 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
EP2968338B1
(en)
|
2013-03-15 |
2019-01-09 |
Intra-Cellular Therapies, Inc. |
Pde1 inhibitors for use in the treatment and/or prevention of cns injuries, and pns diseases, disorders or injuries
|
|
PL2970279T3
(pl)
|
2013-03-15 |
2021-05-31 |
Intra-Cellular Therapies, Inc. |
Związki organiczne
|
|
JP6411342B2
(ja)
|
2013-07-03 |
2018-10-24 |
武田薬品工業株式会社 |
アミド化合物
|
|
WO2015002231A1
(ja)
|
2013-07-03 |
2015-01-08 |
武田薬品工業株式会社 |
複素環化合物
|
|
US20160159808A1
(en)
|
2013-07-24 |
2016-06-09 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
EP3057587A1
(en)
|
2013-10-17 |
2016-08-24 |
GlaxoSmithKline Intellectual Property Development Limited |
Pi3k inhibitor for treatment of respiratory disease
|
|
WO2015055691A1
(en)
|
2013-10-17 |
2015-04-23 |
Glaxosmithkline Intellectual Property Development Limited |
Pi3k inhibitor for treatment of respiratory disease
|
|
TW201625247A
(zh)
|
2014-05-12 |
2016-07-16 |
葛蘭素史密斯克藍智慧財產權有限公司 |
用於治療傳染性疾病之醫藥組合物
|
|
DK3157926T3
(da)
|
2014-06-20 |
2019-08-19 |
Intra Cellular Therapies Inc |
Organiske forbindelser
|
|
US9546175B2
(en)
|
2014-08-07 |
2017-01-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US10285992B2
(en)
|
2014-08-07 |
2019-05-14 |
Intra-Cellular Therapies, Inc. |
Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
|
|
US10131671B2
(en)
|
2014-08-07 |
2018-11-20 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
RU2711442C2
(ru)
|
2014-09-17 |
2020-01-17 |
Интра-Селлулар Терапиз, Инк. |
Соединения и способы
|
|
GB201602527D0
(en)
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
US10034861B2
(en)
|
2016-07-04 |
2018-07-31 |
H. Lundbeck A/S |
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
|
|
JP2019524792A
(ja)
|
2016-08-08 |
2019-09-05 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
化合物
|
|
EP3509589B1
(en)
|
2016-09-12 |
2021-11-17 |
Intra-Cellular Therapies, Inc. |
Novel uses
|
|
GB201706102D0
(en)
|
2017-04-18 |
2017-05-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
GB201712081D0
(en)
|
2017-07-27 |
2017-09-13 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
JP7254078B2
(ja)
*
|
2017-11-27 |
2023-04-07 |
ダート・ニューロサイエンス・エルエルシー |
Ｐｄｅ１阻害剤としての置換フラノピリミジン化合物
|
|
RS62551B1
(sr)
*
|
2017-12-14 |
2021-12-31 |
H Lundbeck As |
Kombinovane terapije koje obuhvataju primenu 1h-pirazolo[4,3-b]piridina
|
|
AR113926A1
(es)
|
2017-12-14 |
2020-07-01 |
H Lundbeck As |
Derivados de 1h-pirazolo[4,3-b]piridinas
|
|
EP3728250A1
(en)
|
2017-12-20 |
2020-10-28 |
H. Lundbeck A/S |
PYRAZOLO[3,4-beta]PYRIDINES AND IMIDAZO[1,5-beta]PYRIDAZINES AS PDE1 INHIBITORS
|
|
US10766893B2
(en)
*
|
2017-12-20 |
2020-09-08 |
H. Lundbeck A/S |
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
|
|
EA202091267A1
(ru)
|
2018-01-12 |
2020-11-03 |
Ориджен Дискавери Текнолоджис Лимитед |
1,2,4-оксадиазольные соединения в качестве ингибиторов сигнальных путей cd47
|
|
US11839614B2
(en)
|
2018-01-31 |
2023-12-12 |
Intra-Cellular Therapies, Inc. |
Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression
|
|
JP7612672B2
(ja)
|
2019-09-03 |
2025-01-14 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
新規化合物
|
|
US12364695B2
(en)
|
2020-06-02 |
2025-07-22 |
Intra-Cellular Therapies, Inc. |
Methods of treating inflammatory disease
|
|
WO2023049199A1
(en)
*
|
2021-09-24 |
2023-03-30 |
Zeno Management, Inc. |
Azole compounds
|
|
EP4644373A1
(en)
*
|
2022-12-28 |
2025-11-05 |
Nippon Soda Co., Ltd. |
Hydrazide compound and agricultural/horticultural bactericidal agent
|